Tag Archive for: Weatherden

Weekly Roundup: Scoring big in biopharma

The World Cup kicked off this week and so did our clients, with new appointments, important clinical trial updates and major collaborations announced! The Optimum team was proud to support and attend Weatherden’s Symposium on Women’s Health yesterday, which featured a stellar line-up of speakers to explore how smarter clinical development and regulatory strategy can […]

Weekly Roundup: Biotech in bloom this June

The heatwave has been replaced by heavy showers, but June is looking bright for our clients, with huge congratulations to Ona Therapeutics for its $86.6M Series B financing and to DaltonTx  for the launch of its AI-enabled drug discovery platform. Dr. Hans Eriksson is joining FundaMental Pharma’s team as CMO and Renée Aguiar-Lucander participated in […]

© Optimum Strategic Communications.